Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults

被引:12
作者
Baesecke, Joerg
Podleschny, Martina
Clemens, Robert
Schnittger, Susanne
Viereck, Volker
Truemper, Lorenz
Griesinger, Frank
机构
[1] Univ Gottingen, Dept Hematol & Oncol, D-37075 Gottingen, Germany
[2] Univ Munich, Klinikum Grosshadern, Med Klin 3, D-8000 Munich, Germany
[3] Univ Gottingen, Dept Gynecol & Obstet, D-37075 Gottingen, Germany
关键词
MLL-PTD; cord blood; healthy newborn; leukemogenesis;
D O I
10.1016/j.leukres.2006.02.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AML-associated MLL-PTD contribute to leukemogenesis by a gain of function and confer an unfavorable prognosis. Like other leukemia associated aberrations they are also present in healthy adults. To delineate the leukemogenic mechanism we tracked down MLL-PTD in normal hematopoiesis and investigated cord blood samples. MLL-PTD were observed in 56/60 (93%) of all cord bloods. In contrast to AML, the transcript frequency in cord blood was four log scales lower as determined by real-time PCR. The CD34+ progenitor cell, CD33+ myeloid, CD19+ B-lymphoid and CD3+ T-lymphoid subfractions were positive. The ubiquitous presence of MLL-PTD in cord blood implicates a lifelong exposure, not an accumulation during lifetime. Since also present in the stem cell subtraction, these factors seem not to be major determinants in MLL-PTD leukemogenesis. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1091 / 1096
页数:6
相关论文
共 27 条
[1]   Transcription of AML1 in hematopoietic subfractions of normal adults [J].
Bäsecke, J ;
Feuring-Buske, M ;
Brittinger, G ;
Schaefer, UW ;
Hiddemann, W ;
Griesinger, F .
ANNALS OF HEMATOLOGY, 2002, 81 (05) :254-257
[2]   Transcription of AML1/ETO in bone marrow and cord blood of individuals without acute myelogenous leukemia [J].
Basecke, J ;
Cepek, L ;
Mannhalter, C ;
Krauter, J ;
Hildenhagen, S ;
Brittinger, G ;
Trumper, L ;
Griesinger, F .
BLOOD, 2002, 100 (06) :2267-2268
[3]   Leukemia- and lymphoma-associated genetic aberrations in healthy individuals [J].
Bäsecke, J ;
Griesinger, F ;
Trümper, L ;
Brittinger, G .
ANNALS OF HEMATOLOGY, 2002, 81 (02) :64-75
[4]  
Biernaux C, 1996, BONE MARROW TRANSPL, V17, pS45
[5]   The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease [J].
Bose, S ;
Deininger, M ;
Gora-Tybor, J ;
Goldman, JM ;
Melo, JV .
BLOOD, 1998, 92 (09) :3362-3367
[6]  
Caligiuri MA, 1998, CANCER RES, V58, P55
[7]   Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics:: A study of the acute myeloid leukemia study group Ulm [J].
Döhner, K ;
Tobis, K ;
Ulrich, R ;
Fröhling, S ;
Benner, A ;
Schlenk, RF ;
Döhner, H .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3254-3261
[8]   Got MLL? Definitive hematopoiesis requires MLL gene expression [J].
Dorshkind, K ;
Witte, O .
MOLECULAR CELL, 2004, 13 (06) :765-766
[9]   Definitive hematopoiesis requires the mixed-lineage leukemia gene [J].
Ernst, P ;
Fisher, JK ;
Avery, W ;
Wade, S ;
Foy, D ;
Korsmeyer, SJ .
DEVELOPMENTAL CELL, 2004, 6 (03) :437-443
[10]   Ten novel 11q23 chromosomal partner sites [J].
Harrison, CJ ;
Cuneo, A ;
Clark, R ;
Johansson, B ;
Lafage-Pochitaloff, M ;
Mugneret, F ;
Moorman, AV ;
Secker-Walker, LM .
LEUKEMIA, 1998, 12 (05) :811-822